Strategies to Reverse Endothelial Progenitor Cell Dysfunction in Diabetes
Open Access
- 1 January 2012
- journal article
- review article
- Published by Hindawi Limited in Experimental Diabetes Research
- Vol. 2012, 1-9
- https://doi.org/10.1155/2012/471823
Abstract
Bone-marrow-derived cells-mediated postnatal vasculogenesis has been reported as the main responsible for the regulation of vascular homeostasis in adults. Since their discovery, endothelial progenitor cells have been depicted as mediators of postnatal vasculogenesis for their peculiar phenotype (partially staminal and partially endothelial), their ability to differentiate in endothelial cell line and to be incorporated into the vessels wall during ischemia/damage. Diabetes mellitus, a condition characterized by cardiovascular disease, nephropathy, and micro- and macroangiopathy, showed a dysfunction of endothelial progenitor cells. Herein, we review the mechanisms involved in diabetes-related dysfunction of endothelial progenitor cells, highlighting how hyperglycemia affects the different steps of endothelial progenitor cells lifetime (i.e., bone marrow mobilization, trafficking into the bloodstream, differentiation in endothelial cells, and homing in damaged tissues/organs). Finally, we review preclinical and clinical strategies that aim to revert diabetes-induced dysfunction of endothelial progenitor cells as a means of finding new strategies to prevent diabetic complications.Keywords
Funding Information
- Ministry of Education, University and Research (RF-FSR-2008-1213704)
This publication has 64 references indexed in Scilit:
- Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouseJournal of Autoimmunity, 2010
- Diabetes Mellitus Induces Bone Marrow MicroangiopathyArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end productsBritish Journal of Pharmacology, 2009
- Endothelial Progenitor Cells Possess Monocyte-like Antigen-presenting and T-cell-Co-stimulatory CapacityTransplantation, 2009
- Diabetes Impairs the Vascular Recruitment of Normal Stem Cells by Oxidant Damage, Reversed by Increases in pAMPK, Heme Oxygenase-1, and AdiponectinThe International Journal of Cell Cloning, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateauAtherosclerosis, 2008
- Decreasing Intracellular Superoxide Corrects Defective Ischemia-induced New Vessel Formation in Diabetic MicePublished by Elsevier BV ,2008
- Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1αJCI Insight, 2007
- Working hypothesis to redefine endothelial progenitor cellsLeukemia, 2007